These breast cancers are divided into 6–10 subtypes that are highly heterogeneous both histologically (Weigelt & Reis-Filho, 2009) and by gene expression profiling (Banerji et al, 2012; Perou et al, 2000; Sorlie et al, 2003): luminal A, luminal B, ERBB2/HER2, normal breast-like, basal-like and triple-negative (TN). Here, ERBB2 is linked to breast carcinoma.